You are here:Home-Chemical Inhibitors & Agonists-Antibiotics and Antivirals-Bacterial-NITD-564
NITD-564

Chemical Structure : NITD-564

CAS No.: 1614262-75-7

NITD-564 (NITD564)

Catalog No.: PC-62532Not For Human Use, Lab Use Only.

NITD-564 is a novel, direct inhibitor of the mycobacterial enoyl-reductase InhA with IC50 of 0.59 uM, exhibits MIC50 of 160 nM against Mtb.

Packing Price Stock Quantity
25 mg Get quote
50 mg Get quote
100 mg Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC) Select Batch:

    Biological Activity

    NITD-564 is a novel, direct inhibitor of the mycobacterial enoyl-reductase InhA with IC50 of 0.59 uM, exhibits MIC50 of 160 nM against Mtb.
    NITD-564 binds specifically to InhA in an NADH-dependent manner and blocks the enoyl substrate-binding pocket.
    NITD-564 shows in vivo efficacy in acute and established mouse models of Mycobacterium tuberculosis infection.

    Physicochemical Properties

    M.Wt 283.371
    Formula C18H21NO2
    Appearance Solid
    CAS No.
    Storage
    Solide Powder
    -20 °C 12 Months; 4°C 6 Months
    In Solvent
    -80 °C 6 Months; -20°C 6 Months
    Shipping
    Solubility

    10 mM in DMSO

    Chemical Name/SMILES

    6-(cyclohexylmethyl)-4-hydroxy-3-phenylpyridin-2(1H)-one

    References

    1. Manjunatha UH, et al. Sci Transl Med. 2015 Jan 7;7(269):269ra3.

    Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

    Contact Us sales@probechem.com

    Bulk Inquiry

    * Indicates a Required FieldYour information is safe with us.

    • *Product name:
    • *Applicant name:
    • *Email address:
    • *Organization name:
    • *Requested quantity:
    • *Country:
    • *Additional Information:

    Get Quote

    * Indicates a Required FieldYour information is safe with us.

    • *Product name:
    • *Applicant name:
    • *Email address:
    • *Organization name:
    • *Requested quantity:
    • *Country:
    • Additional Information: